According to Stratakis et al., the diagnostic criteria for CNC require either two or more major manifestations—such as spotty skin pigmentation, cardiac myxoma, or endocrine tumors—or one major manifestation along with a supplemental criterion, such as a PRKAR1A mutation or an affected first-degree relative. The gene discussed is PRKAR1A; the disease is Carney complex.